Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F91ZF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $90,538
Award facts
- Contract value 100% obligated
- $90,537.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $90,537.99 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 30, 2026, with an ultimate completion date of February 2, 2026. This contract covers the supply of Mounjaro 7.5 mg/0.5 ml pen injections (0.5 ml dosage), a GLP-1 receptor agonist used for diabetes management. The award was made on a non-set-aside, competitive basis, with performance to be executed at the vendor's Conshohocken, Pennsylvania facility. This delivery order operates under Cencora's substantial Indefinite Delivery Contract with the DLA Troop Support Medical (valued at $999,999,999.00 through December 2031), which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities and other government healthcare systems. The company's extensive portfolio of DLA contract awards demonstrates consistent capability to fulfill federal procurement requirements through open competition across diverse product categories. This particular delivery order represents routine pharmaceutical procurement activity consistent with the company's established role as a primary pharmaceutical supplier to the Department of Defense medical supply chain, supporting the delivery of essential medications to military personnel and beneficiaries worldwide.
Quick answers
Who was awarded contract SPE2DR26F91ZF?
SPE2DR26F91ZF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F91ZF worth?
The government has obligated $90,538 on SPE2DR26F91ZF.
Is contract SPE2DR26F91ZF an order under another contract?
Yes. SPE2DR26F91ZF is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91ZF competed?
The extent of competition for SPE2DR26F91ZF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award